Global Health Governance: Addressing Inequities a Decade On

The landscape of global health governance is once again under scrutiny with the announcement of a new Lancet Commission focused on navigating health in a turbulent world. This follows more than a decade after the Lancet–University of Oslo Commission on Global Governance for Health first identified critical weaknesses in how we approach health equity on a global scale. The original 2014 report came at a time when progress was being made toward the Millennium Development Goals, and the Sustainable Development Goals were beginning to take shape. However, even then, advancements were heavily reliant on funding from high-income countries and philanthropic organizations.

The core challenge, as outlined in the initial Commission’s work, isn’t simply a lack of resources, but a systemic failure in how health is governed. The 2014 report pinpointed five key “governance dysfunctions” that perpetuate health inequities: a democratic deficit in health decision-making, weak accountability mechanisms, institutional rigidity that hinders adaptation, gaps in essential institutions, and insufficient policy space for health initiatives to flourish. These aren’t merely technical problems. they are deeply political, reflecting power imbalances and a failure to prioritize health as a fundamental human right.

The Shifting Sands of Global Health Priorities

The context surrounding global health has evolved significantly since 2014. While the MDGs demonstrated the power of focused, measurable goals – addressing poverty, hunger, disease, and other critical issues – the transition to the Sustainable Development Goals (SDGs) signaled a broader, more interconnected approach. The SDGs recognize that health is not isolated, but intrinsically linked to other factors like environmental sustainability, economic development, and social justice. However, this expanded scope also introduces new complexities in governance.

The initial focus on “health security” – often driven by concerns about pandemic threats and bio-terrorism – has, at times, overshadowed the need for broader health equity. Funding and attention have tended to concentrate on areas perceived as directly impacting high-income countries, leaving many vulnerable populations behind. The COVID-19 pandemic starkly illustrated this imbalance, exposing the fragility of global health systems and the consequences of underinvestment in preparedness and equitable access to healthcare.

What the Original Commission Found

The 2014 Commission’s analysis wasn’t simply a critique; it was a call for fundamental change. The “democratic deficit” refers to the limited participation of affected communities in decisions that directly impact their health. Weak accountability means that those in power are often not held responsible for health outcomes. “Institutional stickiness” describes the tendency of organizations to resist change, even when faced with evidence of failure. “Missing institutions” highlight the gaps in global governance structures needed to address cross-border health challenges. And finally, “inadequate policy space” points to the constraints placed on countries – particularly low- and middle-income nations – in their ability to develop and implement health policies that meet their specific needs.

The Political Determinants of Health

A central tenet of the original Commission’s report – and likely to be a key focus of the new iteration – is the understanding that health is profoundly shaped by political factors. This means that addressing health inequities requires more than just medical interventions; it demands tackling the underlying social, economic, and political forces that drive them. Factors like political instability, corruption, discriminatory policies, and lack of access to education and economic opportunities all have a significant impact on health outcomes.

This perspective challenges the traditional, often technocratic, approach to global health, which tends to focus on disease-specific interventions and technical solutions. It argues that true progress requires a more holistic and politically informed approach, one that recognizes the importance of good governance, human rights, and social justice.

What Comes Next: A Renewed Focus on Governance

The launch of a new Lancet Commission signals a recognition that the governance challenges identified in 2014 have not been adequately addressed. In a world facing increasing geopolitical tensions, climate change, and the ongoing threat of pandemics, the need for effective global health governance is more urgent than ever. The Commission’s work will likely involve a comprehensive assessment of the current state of global health governance, identifying emerging challenges and opportunities, and proposing concrete recommendations for reform.

It’s reasonable to expect the new Commission to examine the role of international organizations like the World Health Organization (WHO), the World Bank, and the G20 in shaping global health policy. It will also likely consider the impact of trade agreements, intellectual property rights, and other non-health policies on health outcomes. The Commission may explore innovative governance mechanisms, such as multi-stakeholder partnerships, citizen engagement initiatives, and the utilize of digital technologies to improve transparency and accountability.

The process of developing recommendations will likely involve extensive consultations with a wide range of stakeholders, including policymakers, health professionals, civil society organizations, and affected communities. The ultimate goal will be to develop a roadmap for strengthening global health governance and ensuring that everyone has the opportunity to live a healthy life, regardless of their circumstances. The findings will be crucial for informing policy debates and guiding investments in global health for years to come.

Further details about the scope, membership, and timeline of the new Lancet Commission are expected to be announced in the coming months. Updates and information will likely be available on The Lancet’s website.